3 results match your criteria: "Paris-Saclay University (PSL)[Affiliation]"
Reply to: Unravelling the mysteries of Alveolar soft part sarcomas in young patients.
Eur J Surg Oncol
October 2024
SIREDO Oncology Centre (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris-Saclay University (PSL), Paris, France.
Childhood pancreatic neuroendocrine neoplasms: A national experience.
Pediatr Blood Cancer
February 2025
Unité d'Onco-Hémato-Immunologie pédiatrique, CHU Angers, Angers, France.
Article Synopsis
- Pancreatic neuroendocrine neoplasms (pNENs) are rare in children, with a study examining cases between 2011 and 2020 to understand their clinical presentation and behavior.
- The study analyzed 15 patients, mostly adolescents, and found that a significant number had cancer predisposition syndromes, with some diagnosed through screening.
- Results showed that patients with low-grade tumors had better survival rates, while those with high-grade or metastatic cancers faced poorer outcomes, highlighting the need for improved treatment strategies for severe cases.
Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experience.
Eur J Surg Oncol
September 2024
SIREDO Oncology Centre (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris-Saclay University (PSL), Paris, France.
Background And Aims: Alveolar soft part sarcoma (ASPS) is an ultra-rare chemo-resistant sarcoma in children, occurring preferentially in young adults. We aimed to describe and compare its clinical presentation and behaviour in children and young adults to determine whether the same therapeutic strategy should be addressed for both populations.
Methods: National retrospective multicentre study of children (0-18 years) vs.